Anne-Laure Pham Hung D'Alexandry D'Orengiani

Statistics

Publications

Citations

270

H-Index

Active since

2020

Affiliations

Korea University of Science and Technology(Current)

Finland University

University of Helsinki

Assistance Publique – Hôpitaux de Paris

Institute for Molecular Medicine Finland

Anne-Laure Pham Hung D'Alexandry D'Orengiani is an author at Korea University of Science and Technology specializing in medicine, sickle cell anemia, and sickle cell disease.

Publications per year

2020–2022

Publications

Rapid and severe Covid‐19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab

Gonzalo De Luna, Anoosha Habibi, Jean‐François Deux et al. · American Journal of Hematology · 2020 · 113 citations · Full text

Medicine, Hematology, Acute Care Medicine +12

Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19

Meehyun Ko, So Young Chang, Soo Young Byun et al. · Viruses · 2021 · 78 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19

Meehyun Ko, So Young Chang, Soo Young Byun et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 49 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

Variation and impact of polygenic hematologic traits in monogenic sickle cell disease

Thomas Pincez, Ken Sin Lo, Anne-Laure Pham Hung D'Alexandry D'Orengiani et al. · Haematologica · 2022 · 16 citations · Full text

Life Sciences, Genetics, Hematology +16

Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study

Stéphanie Forté, Gonzalo De Luna, Jameel Abdulrehman et al. · Journal of Clinical Medicine · 2022 · 14 citations · Full text

Medicine, Hematology, Hemostasis +16

1–5 of 5